Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of SBIR/STTR awards granted to Advantagene

List of SBIR/STTR awards granted to Advantagene

List of SBIR/STTR awards granted to Parion Sciences

List of SBIR/STTR awards granted to THREE-DIMENSIONAL PHARMACEUTICALS, INC.

List of SBIR/STTR awards granted to Lenterra, Inc.

List of Plug and Play Real Estate and Construction Batch 1 companies

List of Techstars Class 39 - Barclays 2014 companies

where

SBIR/STTR Award Recipient

is

Advantagene

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ ADVANTAGENE, INC SBIR Phase II Award, August 2018	A SBIR Phase II contract was awarded to Advantagene in August, 2018 for $775,916.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Advantagene		National Institutes of Health	SBIR	4R44CA203336-02	Phase II	775,916	August 1, 2018	sbir.gov/node/1572949
	‌ ADVANTAGENE, INC SBIR Phase I Award, December 2015	A SBIR Phase I contract was awarded to Advantagene in December, 2015 for $299,985.0 USD from the U.S. Department of Health & Human Services.	Advantagene			SBIR	1R44CA203336-01	Phase I	299,985	December 23, 2015	sbir.gov/node/1165097
	‌ ADVANTAGENE, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Advantagene for $101,130.0 USD from the U.S. Department of Health & Human Services.	Advantagene			SBIR	1R44CA124032-01A1	Phase I	101,130		sbir.gov/content/clinical-and-immunologic-evaluation-prostatak-prostate-cancer-0
	‌ ADVANTAGENE, INC SBIR Phase II Award,	A SBIR Phase II contract was awarded to Advantagene for $7,226,590.0 USD from the U.S. Department of Health & Human Services.	Advantagene			SBIR	4R44CA124032-02	Phase II	7,226,590		sbir.gov/content/clinical-and-immunologic-evaluation-prostatak-prostate-cancer-2
	‌ ADVANTAGENE, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Advantagene for $224,999.0 USD from the U.S. Department of Health & Human Services.	Advantagene			SBIR	1R43AA024000-01	Phase I	224,999		sbir.gov/node/704997
	‌ ADVANTAGENE, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Advantagene for $758,386.0 USD from the U.S. Department of Health & Human Services.	Advantagene			SBIR	1R44CA107745-01	Phase I	758,386		sbir.gov/content/clinical-study-adv-tk-radiogene-therapy-glioma-0
	‌ ADVANTAGENE, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Advantagene for $747,384.0 USD from the U.S. Department of Health & Human Services.	Advantagene			SBIR	1R43CA119847-01	Phase I	747,384		sbir.gov/content/clinical-study-gmci-pancreatic-cancer-0
	‌ ADVANTAGENE, INC SBIR Phase II Award,	A SBIR Phase II contract was awarded to Advantagene for $788,188.0 USD from the U.S. Department of Health & Human Services.	Advantagene			SBIR	4R44CA107745-03	Phase II	788,188		sbir.gov/content/clinical-study-adv-tk-radiogene-therapy-malignant-glioma-0
	‌ ADVANTAGENE, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Advantagene for $213,871.0 USD from the U.S. Department of Health & Human Services.	Advantagene			SBIR	1R43CA132468-01	Phase I	213,871		sbir.gov/content/improved-system-producing-adenoviral-vectors-0
	‌ ADVANTAGENE, INC SBIR Phase I Award,	A SBIR Phase I contract was awarded to Advantagene for $100,000.0 USD from the U.S. Department of Health & Human Services.	Advantagene			SBIR	1R43CA099460-01	Phase I	100,000		sbir.gov/content/combination-gm-csf-tkr-gene-therapy-0

10 results

0 selected

10 results

0 selected